Literature DB >> 19653806

Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration.

Robert E Guldberg1.   

Abstract

A primary regenerative medicine strategy is to stimulate or augment endogenous repair mechanisms that promote functional restoration of damaged or degenerated tissues. There is increasing evidence that maximizing the potency of tissue regenerative therapies will require design and development of delivery approaches that provide controlled spatiotemporal release of key signaling molecules. Guidance on which factors to deliver and the timing of delivery is emerging from advances in understanding of critical pathways involved in the development of integrated musculoskeletal tissues. A broad range of biomaterials-based deployment technologies are becoming available that allow controlled spatial presentation and release kinetics of biological cues. The purpose of this perspective article is to review promising spatiotemporal delivery strategies designed to promote functional tissue regeneration with an emphasis on vascularized bone repair.

Mesh:

Substances:

Year:  2009        PMID: 19653806     DOI: 10.1359/jbmr.090801

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  Biomimetic hybrid scaffolds for engineering human tooth-ligament interfaces.

Authors:  Chan Ho Park; Hector F Rios; Qiming Jin; Megan E Bland; Colleen L Flanagan; Scott J Hollister; William V Giannobile
Journal:  Biomaterials       Date:  2010-05-14       Impact factor: 12.479

2.  Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect Repair.

Authors:  Chunlan Huang; Vincent P Ness; Xiaochuan Yang; Hongli Chen; Jiebo Luo; Edward B Brown; Xinping Zhang
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

Review 3.  Implantable Sensors for Regenerative Medicine.

Authors:  Brett S Klosterhoff; Melissa Tsang; Didi She; Keat Ghee Ong; Mark G Allen; Nick J Willett; Robert E Guldberg
Journal:  J Biomech Eng       Date:  2017-02-01       Impact factor: 2.097

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 5.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

6.  An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects.

Authors:  Yash M Kolambkar; Kenneth M Dupont; Joel D Boerckel; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Biomaterials       Date:  2010-09-22       Impact factor: 12.479

Review 7.  Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair.

Authors:  Rachit Agarwal; Andrés J García
Journal:  Adv Drug Deliv Rev       Date:  2015-04-08       Impact factor: 15.470

8.  Investigation of Postnatal Craniofacial Bone Development with Tissue Clearing-Based Three-Dimensional Imaging.

Authors:  Wenjing Luo; Yating Yi; Dian Jing; Shiwen Zhang; Yi Men; Woo-Ping Ge; Hu Zhao
Journal:  Stem Cells Dev       Date:  2019-09-09       Impact factor: 3.272

9.  Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials.

Authors:  Nicole Feric; Calvin C H Cheng; M Cynthia Goh; Vyacheslav Dudnyk; Val Di Tizio; Milica Radisic
Journal:  Biomater Sci       Date:  2014-10-01       Impact factor: 6.843

Review 10.  Application of drug delivery systems for the controlled delivery of growth factors to treat nervous system injury.

Authors:  Fukai Ma; Fan Wang; Ronggang Li; Jianhong Zhu
Journal:  Organogenesis       Date:  2018-08-27       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.